Name | Title | Contact Details |
---|
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
Calimmune, Inc., a clinical-stage human immunodeficiency virus (HIV) gene medicines company, develops cell-based therapies for HIV. The company offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. It also focuses on developing products to address the needs of various types of individuals at different states of HIV infection and with different levels of treatment experience..
ViTel Net is a Mc Lean, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bayer's A1CNow+ Headquarters is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Scientist is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.